Neogen Corporation is a company that specializes in developing and marketing innovative solutions for food and animal safety. Its product portfolio includes a wide range of diagnostic tests, natural antiseptics, and other technologies designed to detect foodborne pathogens, allergens, and other contaminants. Neogen serves diverse markets, including food processors, restaurants, and agriculture. By providing tools that help ensure the safety and quality of food products, Neogen plays a critical role in promoting public health and supporting higher standards in food production and processing. Read More
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fea...
Neogen (NASDAQ:NEOG) reported fiscal 2027 first-quarter revenue of $222.8 million, with core growth of 8.1%, as the company cited improved commercial execution, product-line strength in food safety and animal safety, and progress on its Petrifilm manufacturing transition.
Chief Executive Officer Mi
Life sciences company Neogen (NASDAQ:NEOG) reported calendar Q3 2026 (fiscal Q1 2027) results exceeding the market’s revenue expectations, with sales up 6.5%...
NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced its financial results for the first quarter of fiscal year 2027.
Neogen® Corporation (NASDAQ: NEOG), a global leader in food safety solutions, is advancing its innovation strategy by combining deep food safety expertise with emerging technologies to introduce novel solutions to the Food Safety industry that address evolving customer challenges. As part of that strategy, Neogen today announced a strategic collaboration with and an equity investment in Hinalea Imaging Corp. to develop digital imaging solutions for food safety and quality inspection.
NEW YORK CITY, NY / ACCESS Newswire / October 5, 2026 / Multiple fungal species, identified through FDA testing in a Neogen Vet product marketed as sterile, drove Neogen Corporation (NASDAQ:NEOG) shares down 7.22%. If you bought NEOG and are now holding a loss, you have legal rights. Shareholders who lost money on Neogen are encouraged to submit their loss information now while the investigation is underway. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.
Life sciences company Neogen (NASDAQ:NEOG) will be announcing earnings results this Tuesday after market hours. Here’s what to expect. Neogen beat analysts’ ...
Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Neogen Corporation (“Neogen” or “the Company”) (NASDAQ: NEOG) for violations of the securities laws.
Neogen (NASDAQ:NEOG) shareholders approved all five proposals presented at the company’s 2026 annual meeting, including the election of three directors, advisory approval of executive compensation, and amendments to the company’s equity incentive and employee stock purchase plans.
Chair of the Boar
Law Offices of Howard G. Smith announces an investigation on behalf of Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG) investors concerning the Company’s possible violations of federal securities laws.
The Law Offices of Frank R. Cruz announces an investigation of Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG) on behalf of investors concerning the Company’s possible violations of federal securities laws.
What Happened? Shares of life sciences company Neogen (NASDAQ:NEOG) fell 5.4% in the afternoon session after the U.S. Food and Drug Administration issued war...
“You get what you pay for” often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the ...
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from eleva...
Neogen® Corporation (NASDAQ: NEOG) will issue its first-quarter earnings release after the closing of the market on October 6, 2026. Executives from the company will host a webcast and conference call beginning at 4:30 p.m. Eastern time, to discuss the financial results.
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size ...
Over the past six months, Neogen has been a great trade, beating the S&P 500 by 8.3%. Its stock price has climbed to $11.93, representing a healthy 21% incre...
Neogen® Corporation (NASDAQ: NEOG) announced today that it will host an Investor Day on Wednesday, October 7, 2026, at 9 a.m. ET in New York City. The focus of the event will be on Neogen’s strategic transformation as the Company provides additional details on its commercial prowess, high-impact innovation, and operational excellence to drive sustainable improvement in financial performance.
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha...
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline...
